Previous research indicates there may be an association between inflammation and depression in older adults but results are inconsistent. Therefore, the aim of this review was to determine the cross-sectional and longitudinal associations of two inflammatory markers C-reactive protein (CRP) and Interleukin-6 (IL-6) with depression in older adults. We searched five databases for cross-sectional and longitudinal studies reporting an association between CRP or IL-6 with depression among adults sampled from the community aged 50 or older. We found 32 studies (23 cross-sectional, 7 longitudinal, and 2 assessing both cross-sectional and longitudinal associations) that met eligibility criteria. These studies were entered into a random-effects meta-analysis to determine the cross-sectional association and longitudinal direction of association between both IL-6 and CRP with depression.
Introduction
Estimates suggest that 1% to 12% of community-dwelling older adults are affected by major depression (Copeland et al., 2004; Fiske et al., 2009; Hasin et al., 2005) , while depressive symptoms are present in 10% to 39% of community-dwelling older adults (Blazer, 2003; Djernes, 2006; García-Peña et al., 2008) . Depressive symptoms among older adults can adversely affect quality of life in terms of functioning and well-being (Penninx et al., 1998) and also increase the risks for morbidity and mortality (Lee et al., 2001; Fiske et al., 2009; Blazer and Hybels, 2005) .
One biological theory that could explain depression in older adults is the inflammatory theory of depression. This theory posits that increased levels of inflammation can cause depression (Anisman, 2009; Dantzer et al., 2008b; Slavich and Irwin, 2014; Alexopoulos and Morimoto, 2011) . It is possible that this biological theory of depression could be especially important for older adults as they tend to have higher circulating levels of inflammation than younger adults (Krabbe et al., 2004; Bruunsgaard et al., 2001; Chung et al., 2011; Chung et al., 2009) , and they also have an increased risk of chronic illness (Wolff et al., 2002) which is associated with increased inflammation.
Two indicators of inflammation commonly examined in relation to depression are the acute-phase protein C-reactive protein (CRP) and the proinflammatory cytokine Interleukin-6 (IL-6). CRP is a non-specific marker of inflammation, infection, and tissue damage (De Berardis et al., 2009) shown to be linked with depression (Haapakoski et al., 2015; Howren et al., 2009; Valkanova et al., 2013) . IL-6 is a broad acting inflammatory cytokine that has a role in stimulating an immune response to stressors such as fever (Hunter and Jones, 2015) . IL-6 has been shown to be increased in the bloodstream of older adults (Ershler and Keller, 2000; Hager et al., 1994) , and has also been linked with depression (Haapakoski et al., 2015; Howren et al., 2009) .
There have been three previous meta-analyses that have investigated the association of depression with both CRP and IL-6. The first review conducted by Howren et al. (2009) found a positive association between both CRP and IL-6 with depression. However, the collection of studies were restricted to cross-sectional designs and the meta-analysis consisted of all age groups with no subgroup analysis based on age. A second meta-analysis published by Haapakoski et al. (2015) found a moderate association between both CRP and IL-6 with major depression as diagnosed by structured clinical interviews across twenty and thirty one studies, respectively. However, most studies were conducted in clinical populations meaning results might not be applicable to a community sample, and no subgroup analysis based on age was provided. A third meta-analysis used only longitudinal studies and found a small association between raised CRP levels with subsequent development of depressive symptoms and a trend towards significance for IL-6 (Valkanova et al., 2013) . However, this study was based on eight studies and only three studies assessed the association between CRP and depression specifically among older adults, while only three studies examined IL-6 and depression in total for all age groups. Two additional meta-analyses investigated the association of IL-6 with depression, and both found a significant positive association (Dowlati et al., 2010; Hiles et al., 2012) . However, neither conducted an agespecific subgroup analysis.
Previous work that has been undertaken in older adults examining the association between inflammation and depression has found inconsistent results with some studies indicating an association (Lu et al., 2013; Penninx et al., 2003b) and some indicating no association (Stewart et al., 2008; Valentine et al., 2011) . These differences make interpretation of the literature difficult. Researchers have pointed to differences in study populations, gender, assessment of depression, inflammatory marker investigated and adjustment for important confounders such as chronic conditions or adiposity as being possible reasons for inconsistency in results (Almeida et al., 2007; Au et al., 2015; Das, 2016; Hiles et al., 2015) . A previous meta-analysis by Hiles et al. (2012) undertook a comprehensive assessment of sources of heterogeneity in studies that examined depression and IL-6 in all age groups. They found that results varied by depression assessment, population setting (i.e., inpatient, outpatient or community) and presence of chronic conditions (Hiles et al., 2012) . Thus, considering sources of heterogeneity across studies may be important for uncovering why inconsistencies in results may exist. However, we lack work that has systematically investigated potential sources of heterogeneity in older adults.
Given the paucity of synthesis that has explicitly examined the link between CRP and IL-6 with depression in older adults, the main aim of this review was to examine the relationship between both CRP and IL-6 with depression in community-based samples of adults aged 50 or older. Further, due to the inconsistency in findings from previous work we undertook a comprehensive qualitative and quantitative assessment of potential sources of heterogeneity that could explain differences in findings.
Methods

Search strategy
A systematic literature search for studies describing the relationship between CRP or IL-6 with depression was undertaken between January 2017 and May 2017 (with an update undertaken in September 2017). No language restriction was implemented, but only English papers were reviewed. Furthermore, no restriction was placed on date of publication, type of analysis employed or length of follow-up for longitudinal studies.
Three search themes, "C-reactive protein", "Interleukin-6" and "depression" were combined using the Boolean operator "and." (see Appendix A) in five major databases: MEDLINE via PUBMED (United States National Library of Medicine, Bethesda, MD, USA), EMBASE (Elsevier, Amsterdam, Netherlands), PsycINFO (American Psychological Association, Washington, DC, USA), ISI Web of Knowledge (Thomson Reuters, New York, NY, USA), and ProQuest (ProQuest, Ann Arbor, MI, USA). In addition, we manually searched the reference lists of all identified relevant published primary studies and review articles.
Study selection
Individual studies were considered for inclusion in the systematic review if they assessed the relationship between either CRP and depression in a community sample of adults 50 or older or they assessed the relationship between IL-6 and depression in a community sample of adults 50 or older. Furthermore, the following inclusion criteria were specified: 1) the authors reported data from an original, observational peer-reviewed journal article (i.e., not review articles, reports, letters, theses, posters, published abstracts or comments); 2) the authors provided cross-sectional or longitudinal associations (or both) between CRP and depression or IL-6 and depression; 3) depression was measured with a validated scale or determined using a diagnostic framework or clinical interview (e.g., ICD or DSM) 4) the study population was a cohort of non-institutionalized older adults (age ≥ 50 years at baseline); 5) for prospective studies, the study accounted for/controlled for baseline levels of their outcome. Only studies where participants were sampled from the community were included because the epidemiological inferences are more easily applicable to the general population. Within this definition, we included any study where participants were community-dwelling older adults who have been sampled from primary care. Chronic disease populations (i.e., cancer, diabetes, cardiovascular disease, uremia, renal disease, or respiratory disease) were excluded as were intervention studies. For publications using the same study cohort, the higher quality publication was included for final analysis. When both publications had the same quality rating, the paper that analyzed the larger number of participants was included.
Two authors (L.O. and K.J.S.) firstly screened the titles and abstracts of identified studies (see Fig. 1 ). Full-text articles were then screened by two authors (B.A and K.J.S). Discrepancies were resolved by consensus, or, when necessary, by a third author (N.S.). Those studies that were eligible for inclusion following full-text analysis were put forward for data extraction and quality assessment.
Data extraction and quality assessment
Data extraction and quality assessment of eligible studies were performed independently by two reviewers (B.A. and K.J.S.). The following information was extracted: study characteristics, participants' characteristics at baseline, method of assessment for depression, method of assessment for CRP and IL-6, analysis strategy, and brief results (least adjusted and most adjusted effect measure was reported if available). For the purpose of this review, the term 'depression' is used as a general descriptor that incorporates any assessment of depression (i.e., depressive symptoms or clinical depression). Clinical depression refers to studies where clinical diagnostic criteria were used to determine depression, while depressive symptoms refer to studies that examined depression using a symptom scale.
The quality of both cross-sectional and longitudinal studies was assessed using the modified Newcastle-Ottawa Scale (NOS) for observational studies. The NOS is a comprehensive instrument that has established content validity and inter-rater reliability (Wells et al., 2014; Gariepy et al., 2010) . The interpretation of the scale is based on a "star" system wherein a study is assessed on three broad categories: the selection of study groups; the comparability of the study groups; and the measurement of exposure/outcome. Only those studies determined to be of a minimum moderate quality were selected for the meta-analysis (see Appendix B for quality assessments).
Statistical analysis
We analyzed cross-sectional and longitudinal associations separately. Data were combined with random-effects models as these provide more conservative estimates, which are appropriate for our analyses given the potential methodological and analytical heterogeneity across studies. Where results were stratified (e.g., by gender) we firstly combined these in order to enter one estimate for each study. We computed correlation coefficients (r) with their corresponding 95% confidence intervals (CI) and graphically presented these on Forest plots. The majority of the studies reported both unadjusted and adjusted findings. Therefore, we separated these results into two groups to make them more comparable: 1) "least adjusted r" (either unadjusted r or r adjusted for basic covariates age and sex) and 2) "most adjusted r" (the value from the fully adjusted model). Heterogeneity was examined by calculating the Cochrane Q statistic and the inconsistency index (I  2 ) statistic. The Cochrane Q statistic is distributed as χ 2 and tests whether the individual effects are farther away from the common effect beyond what is expected by chance (a p-value < 0.10 indicates significant heterogeneity). The I 2 statistic is the percentage of total variability in effect measure that is attributable to variation across studies (a value of 25%, 50%, and 75% indicates low, medium, and high heterogeneity respectively). Publication bias was assessed visually using Funnel plot and statistically with Egger's regression intercept test. All statistical analyses were conducted using Comprehensive Meta-Analysis Software (version 3.0 Biostat, Englewood, NJ, USA).
Results
Study selection
A total of 7573 studies were identified in our initial search (see Fig. 1 ). Studies were assessed using broad screening criteria (e.g., Papers put forward for data extraction and quality assessment (n=41)
Studies excluded from final screen -Study replication (n=3) -Insufficient data (n=5) -Included data from non-observational study (n=1)
Final selected studies for systematic review and meta-analysis (n= 32) -Cross-sectional studies (=21) -Longitudinal studies (n=7) -Cross-sectional and longitudinal studies (n=4) Fig. 1 . Flowchart of search strategy. K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 suitability of study population, design, exposure or outcome) and 7428 studies were rejected including duplicates. Following this 145 potentially relevant publications were put forward for full-text screening with 104 excluded. The primary reasons for rejection were non-representative sample, below age requirement, or no measure of association between CRP and depression. This left 41 potential studies for quality assessment, nine of which were excluded due to study sample duplication (whichever publication that was of lower quality or that used a subset of participants were excluded), inability to extract data and design unsuitability (see Fig. 1 ). We were left with thirty two studies for the systematic review and meta-analysis. Two studies contained both cross-sectional and prospective analyses, twenty three studies provided cross-sectional data, and seven studies provided prospective analyses (see Tables 1-3) . Inter-rater agreement for studying screening was good (kappa = 0.72 ± 0.06). Table 1 summarizes the characteristics and main findings of the twenty five cross-sectional analyses, Table 2 describes results of the eight longitudinal studies that examined the direction of association from CRP to depression and/or IL-6 to depression and Table 3 describes results of four studies that examined the direction of association from depression to CRP and/or depression to IL-6. The quality assessment results from the cross-sectional and longitudinal studies are included in Appendix B. Studies included in this review were published between 1999 and 2016.
There were ten studies from Europe, twelve from North America, five from Asia, and three from Australia. Sample size ranged from 64 to 5438 participants, with a total of 42,606 individuals from cross-sectional analyses and 13,337 individuals from prospective analyses included in this review.
Study review and meta-analysis of cross-sectional association between CRP and depression
Association between CRP and depression: Main results
Twenty two studies conducted cross-sectional analyses on the association between CRP and depression. There were 17 studies that examined the least-adjusted relationship between CRP and depression and 17 studies that examined the most-adjusted relationship between CRP and depression. Of those 17 studies that examined the least adjusted relationship between CRP and depressive symptoms, seven of them found a significant positive association (Almeida et al., 2007; Hiles et al., 2015; Kop et al., 2002; Lu et al., 2013; Nadrowski et al., 2016; Smagula et al., 2014; Song et al., 2015) . Of those 17 studies that examined the most-adjusted relationship, only three found a significant positive association (Ma et al., 2011; Penninx et al., 2003a; Song et al., 2015) .
The random effects summary correlation coefficient for those studies that reported least adjusted estimates showed a positive association between CRP levels and depressive symptoms (Fig. 2a) . The effect was small yet highly significant, r = 0.043 (95% CI: 0.031-0.056), p < 0.001. For the studies that reported fully adjusted results (Fig. 2b) , the association was attenuated, r = 0.010 (95% CI: −0.009-0.028), p = 0.308. The I 2 was 0% and the Q statistic was 13.32 (p = 0.65) for the least adjusted analysis and the I 2 was 35.36% and the Q statistic was 24.75 (p = 0.07) for the most adjusted analysis. This suggests statistical heterogeneity was low-moderate for these analyses. The funnel plots (Appendix C) were generally symmetric, though there was an outlying study in the least adjusted analysis (likely the extreme non-significant result found by Forti). Finally, Egger's test produced a non-significant Pvalue for the least adjusted (0.40) but not the most adjusted analyses (0.04). This suggests there may have been publication bias for the most adjusted studies. (See Fig. 3.) 3.2.1.1. Heterogeneity: Qualitative synthesis. There was notable heterogeneity between studies in terms of depression assessment, analytic strategies, population studied and confounders controlled for.
Of the twenty two studies only twelve provided both a least and mostadjusted estimate, the remaining ten studies either provided the least or most adjusted estimate (see Table 1 ). There was heterogeneity observed between studies in the measurement of depression. All twenty two studies assessed depression using a validated depression rating scale, and three studies provided additional estimates for the relationship of CRP with clinical depression. However, none of the three studies that assessed the relationship between CRP and clinical depression reported a significant relationship for either the least or most adjusted estimates (Bremmer et al., 2008; Forti et al., 2010; Tiemeier et al., 2003b) . There were also differences observed in how depressive symptoms were modelled in the statistical analysis. Some studies modelled depressive symptoms continuously, others modelled them categorically (see Table 1 ). Where depressive symptoms were modelled categorically the cut-offs tended to be based on validated cut-offs, however this was not always consistent between studies. For example, of the four studies that used the GDS-15 categorically one used a cut-off of ≥ 5 (Lu et al., 2013) , one used ≥6 (Smagula et al., 2014) and two used ≥ 7 (Almeida et al., 2007; Nadrowski et al., 2016) .
Alongside heterogeneity in how depressive symptoms were modelled, there was also heterogeneity in how CRP was modelled statistically with some studies examining this variable continuously and others categorically. When modelled categorically there was notable heterogeneity between studies. Some studies used clinically defined cut-offs (Almeida et al., 2007; Hamer and Chida, 2009 ), but most used datadriven cut-offs such as the median or quartiles (Bremmer et al., 2008; Forti et al., 2010; Lu et al., 2013; Nadrowski et al., 2016; Pan et al., 2008; Penninx et al., 2003a) . This meant that the range used to define high CRP across studies varied between ≥ 1.51 mg/L (Pan et al., 2008) and > 9.65 g/dL (Lu et al., 2013) .
Another source of heterogeneity that was observed between studies was the modelling of the exposure and outcome. Seven of the included studies examined depression as the exposure and CRP as the outcome (Kop et al., 2002; Loucks et al., 2006; Ma et al., 2011; Mezuk et al., 2016; Milaneschi et al., 2009; Stewart et al., 2008; Tiemeier et al., 2003a) , whereas the remaining studies examined inflammation as the exposure and depression as the outcome The majority of studies that found significance for the least adjusted (six out of seven studies) and most adjusted (two out of three studies) analysis examined CRP as their exposure and depression as the outcome (see Table 1 ).
In terms of confounders controlled for heterogeneity was also evident, three studies controlled for no confounders (Lu et al., 2013; Matsushima et al., 2015; Valentine et al., 2011) whereas others controlled for a variety of factors known to influence depression and inflammation including sociodemographics, lifestyle, chronic conditions, medication and adiposity (see Table 1 ). Those studies that included both a least and most adjusted association tended to find that significant least-adjusted results were attenuated after adjustment for confounders (Almeida et al., 2007; Kop et al., 2002; Smagula et al., 2014) . However, one study conducted in 2242 American women became significant after adjustment for confounders (Ma et al., 2011) , and a second study conducted in 569 older Korean's remained significant in men after adjustment for confounders (Song et al., 2015) .
Another source of heterogeneity between studies was the health of the sample. For example, five studies excluded participants with very high levels of CRP indicative of systemic inflammation (see Appendix B). Of these five studies, only one conducted in 1410 Australian older adults found a significant association between CRP and depression (Hiles et al., 2015) . Furthermore, seven studies excluded people with different chronic conditions, meaning the population studied could have been healthier than other populations included within the review (Baune et al., 2012; Kop et al., 2002; Lu et al., 2013; Mezuk et al., 2016; Pan et al., 2008; Smagula et al., 2014; Stewart et al., 2008; Valentine et al., 2011) . However, three of these seven studies did find a significant result, so there is no indication exclusion of people with chronic recent infection, and current use of antiinflammatory medication, study site. Smith et al. Experimental Gerontology 102 (2018) Smoking, drinking, physical activity BMI, log-triglyceride, log-insulin, log-total cholesterol, use of anti-inflammatory medication, presence of co-morbidity. Inventory of Depressive Symptomatology; IL-6: Interleukin-6; MI: Myocardial infarction; MMSE: mini-mental state examination; NSAID: Nonsteroidal anti-inflammatory drugs; OR: odds ratio; Q: Quartile (e.g., Q3 = quartile 3); SDV: Sociodemographic variables; SD: standard deviation; SE: standard error; SEM: standard error of mean; SPPB: Short Physical Performance Battery. † Indicates studies where depression was the predictor and inflammation the outcome in the analysis (if no † there was no directionality in the analysis or inflammation was the predictor and depression the outcome).
Non-adjusted effect measures or effect measures adjusted exclusively for only age and/or sex were considered "Least adjusted"; Fully-adjusted effect measures or effect measures adjusting for any additional demographic, lifestyle or clinical covariates were considered "Most adjusted."
K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 conditions systematically influenced results (see Table 1 ). There were also sociodemographic differences between the samples, with some studies having a minimum age of 50 for inclusion and others 70. However, closer examination of significant results revealed no systematic differences in the association between CRP and depression based on age of inclusion (see Table 1 ). Some studies also provided gender stratified estimates or were only conducted in one gender. Of those studies conducted in men all four of studies that investigated the least adjusted estimate found a significant association (Almeida et al., 2007; Hiles et al., 2015; Smagula et al., 2014; Song et al., 2015) , however in women only one of three studies found a significant least adjusted association (Hiles et al., 2015) . Notably, after controlling for confounders most of these relationships were reduced to non-significance.
3.2.1.2. Heterogeneity: Quantitative synthesis. To ascertain whether the observed heterogeneity had an impact on the least or most adjusted estimate, we ran a series of sensitivity analyses (see Table 4 ). Our analyses indicated that most results remained unchanged when stratifying by sociodemographics, statistical/methodological differences and diagnostic cutpoints. However, in those crosssectional analyses that examined CRP as the exposure and depression as the outcome, the fully adjusted estimate was significant (r = 0.032 [95% CI: 0.008-0.057], p = 0.011). This indicated that the while heterogeneity was indicated in study methodology, participants, analytic strategies and confounders controlled for that that these differences did not substantially impact overall meta-analytic estimates.
3.3. Study review and meta-analysis of cross-sectional association between IL-6 and depression
Association between IL-6 and depression: Main results
In total there were seventeen studies that examined the cross-sectional association of IL-6 with depression, with fourteen examining the least-adjusted association and thirteen examining the most adjusted association. In studies that examined the association between IL-6 and depression, seven out of fourteen studies found at least one significant positive association for the least adjusted estimate (Dentino et Forti et al., 2010; Lu et al., 2013; Nadrowski et al., 2016; Pan et al., 2008; Smagula et al., 2014; Hiles et al., 2015) , and six out of thirteen studies found a significant positive association for the most adjusted estimate (Baune et al., 2012; Dentino et al., 1999; Forti et al., 2010; Hiles et al., 2015; Nadrowski et al., 2016; Penninx et al., 2003a) . The random effect summary correlation coefficients for IL-6 and depression indicated a significant association for both the least and most adjusted estimates. The correlation coefficients for the least and most adjusted estimates were r = 0.050 (95% CI: 0.035-0.066), p < 0.001 and r = 0.032 (95% CI: 0.010-0.054), p < 0.005, respectively. For the least adjusted analysis the I 2 was 3.0% and the Q statistic was 13.44 (p = 0.41), and for the most adjusted analysis the I 2 was 12.57% and the Q statistic was 13.73 (p = 0.32). This suggests statistical heterogeneity was low for both analyses. The funnel plots (Appendix C) were generally symmetric and Egger's test produced a non-significant P-value for the least adjusted (0.58) and most adjusted analyses (0.76) suggesting no publication bias.
3.3.1.1. Heterogeneity: Qualitative synthesis. There was heterogeneity between those studies that examined the association between IL-6 and depression for depression assessment, statistical analysis, populations and confounding (see Table 1 ). Heterogeneity was observed in the measurement of depression. Most of the included studies examined depressive symptoms using the CES-D and GDS (see Table 1 ). However, an additional four studies examined clinical depression. All fours studies that examined clinical depression and IL-6 found a significant relationship (Bremmer et al., 2008; Dimopoulos et al., 2008; Forti et al., 2010; Tiemeier et al., 2003a) , which remained significant after controlling for confounders. Whereas results for depressive symptoms and IL-6 were more variable (see Table 1 ). When examining exposures and outcomes, five of the 17 studies modelled depression as the exposure and IL-6 as the outcome (Dimopoulos et al., 2008; Friedman et al., 2007; Nadrowski et al., 2016; Stewart et al., 2008; Tiemeier et al., 2003a) with the remaining studies modelling IL-6 as the exposure and depression as the outcome (see Table 1 ). Of the five studies that modelled depression as the exposure only one found a significant association (Nadrowski et al., 2016) , the remaining significant associations were in those studies modelling IL-6 as their exposure (see Table 1 ).
There was also heterogeneity in how studies modelled IL-6 (continuous or categorical) and depression (continuous or categorical). Like CRP, there was notable heterogeneity in the cut-offs used for categorising IL-6 with the range used to define high IL-6 ranging from ≥ 1.08 pg/mL (Smagula et al., 2014) Fig. 3 . Forest plots of cross sectional association between IL-6 and depression.
K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 2008). However, closer examination of results indicated no systematic differences in significance of results based on how IL-6 or depression was modelled statistically or differences in cut-offs used (see Table 1 ). As with CRP there was notable heterogeneity in terms of confounders controlled for. There were four studies that only provided unadjusted estimates (Dimopoulos et al., 2008; Lu et al., 2013; Matsushima et al., 2015; Valentine et al., 2011) , and one only controlled for sociodemographics (Dentino et al., 1999 K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 Table 4 Sensitivity analyses for cross-sectional associations. Table showing sub-group analyses for cross-sectional analyses. Where stratification has affected the significance of the estimate this is indicated by *. Insufficient data indicates where one or no estimates were available. K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 majority of included studies controlled for a range of sociodemographic, lifestyle, health and medication-related variables (see Table 1 ). Of the six studies that found a most adjusted significant result only one did not adjust for medication, adiposity and/or chronic conditions (Dentino et al., 1999) . Furthermore, in those nine studies that provided both a least adjusted and most adjusted estimate the addition of confounders into the statistical model did not change results for six studies. In the remaining three studies statistically significant results were attenuated by the inclusion of confounders (Hiles et al., 2015; Pan et al., 2008; Smagula et al., 2014) . However, in Hiles et al. (2015) the inclusion of confounders into the statistical model meant that the previously non-significant least adjusted result for men became borderline significant in the most adjusted result. When compared on the health of participants there was also heterogeneity between studies. Two studies excluded participants on the basis of systemic inflammation (Hiles et al., 2015; Stewart et al., 2008) , however as one study found significance and the other did not there is no evidence this would affect estimates (see Table 1 ). There were seven studies that made exclusions to their populations on the basis of having chronic conditions (Baune et al., 2012; Dimopoulos et al., 2008; Lu et al., 2013; Pan et al., 2008; Smagula et al., 2014; Stewart et al., 2008; Valentine et al., 2011) . However, as four of these studies found at least one significant result there is no indication that exclusion of chronic conditions systematically affected results (see Table 1 ).
There was also some heterogeneity between studies by age of inclusion, which ranged from 50 to 70 (see Table 1 ). Of note, five of the six studies that found significance in the most adjusted result had a minimum age of 65 (Baune et al., 2012; Dentino et al., 1999; Forti et al., 2010; Hiles et al., 2015; Nadrowski et al., 2016; Penninx et al., 2003a) . In terms of gender only one study provided gender stratified estimates (Hiles et al., 2015) and found a significant association between IL-6 and depression for the least adjusted analysis in women but not men. However, in the most adjusted analysis the significant association in women was attenuated and the association for men became significant (Hiles et al., 2015) . One additional study explored the association of IL-6 and depression in men only but found no significant result (Smagula et al., 2014) .
3.3.1.2. Heterogeneity: Quantitative synthesis. To determine whether any of these sources of heterogeneity could impact the estimates we ran a series of stratified sensitivity analyses (see Table 4 ). When stratifying for various statistical/methodological, diagnostic and demographic factors the least adjusted estimate remained significant except when we only examined those studies that excluded people with chronic conditions at baseline. The most adjusted estimate was no longer significant when we only included those studies where they adjusted for chronic conditions or removed people with chronic conditions from their analysis. It was also non-significant when we only examined those studies that did not exclude people with systemic inflammation. In studies where depression was examined continuously and in studies where IL-6 was assessed either categorically or continuously, the results become non-significant after adjustment for confounders (see Table 4 ). This indicates the relationship between IL-6 and depression may be influenced by systemic inflammation and chronic conditions.
Finally we performed an analysis to examine the association of clinical depression with IL-6. There were four studies (Bremmer et al., 2008; Dimopoulos et al., 2008; Forti et al., 2010; Tiemeier et al., 2003a) that examined this association and the correlation coefficient from the random effects meta-analysis was significant for both the least and most adjusted estimate: (r = 0.115 [95% CI: 0.072-0.158], p ≤0.001) and (r = 0.035 [95% CI: 0.035-0.174], p = 0.003), respectively.
3.4. Study review and meta-analysis of the prospective association between CRP and depression 3.4.1. Prospective association between CRP and depression A total of eight studies examined the direction of association from CRP to depression (see Table 2 ), and four examined the direction of association from depression to CRP (see Table 3 ). Of these studies, three examined the bi-directional association between CRP and depression (Au et al., 2015; Das, 2016; Stewart et al., 2009 ).
3.4.1.1. CRP to depression: Main results. There were six studies that examined the least adjusted association between CRP to depression. Of these studies, four found a significant association between CRP at baseline with depression at follow-up (Au et al., 2015; Luukinen et al., 2010; van den Biggelaar et al., 2007; Zalli et al., 2016) . For the most adjusted analysis, five studies found a significant association between CRP at baseline with depression at follow-up (Das, 2016; Luukinen et al., 2010; Stewart et al., 2009; van den Biggelaar et al., 2007; Zalli et al., 2016 ) (see Table 2 ).
When the results for the least adjusted estimate were combined using a random effects meta-analysis, a positive correlation between CRP at baseline and depressive symptoms at follow-up was found (Fig. 4a) . The effect was small but significant, r = 0.074 (95% CI: 0.006-0.142), p = 0.033. For the seven studies that reported fully adjusted results (Fig. 4b) , the strength of the correlation increased slightly and remained statistically significant, r = 0.074 (95% CI: 0.031-0.116), p = 0.001.
The I 2 for the least and most adjusted analyses were 64.18% and 35.24% respectively. The Q statistic for the least adjusted analysis was 16.75 (p = 0.01) and the most adjusted analysis was 10.81 (p = 0.15). This indicated moderate-high and significant heterogeneity for the least adjusted analysis and moderate and non-significant heterogeneity for the most adjusted analysis. The funnel plot for the least adjusted analyses (Appendix C) were fairly symmetric and Egger's test produced a non-significant P-value (0.9), which represents an absence of publication bias. However, the funnel plot for the most adjusted analysis and Egger's test (P-value 0.008) were suggestive of borderline positive publication bias.
Depression to CRP: Main results
Of the four studies that examined the relationship between depression at baseline and CRP at follow-up, none found significant results for either the least or most adjusted analyses (Au et al., 2015; Das, 2016; Luciano et al., 2012; Stewart et al., 2009) . Two studies provided a least adjusted estimate (Au et al., 2015; Luciano et al., 2012) and four provided a most adjusted estimate (Au et al., 2015 , Das, 2016 , Luciano et al., 2012 , Stewart et al., 2009 ). When we combined the least adjusted and most adjusted analyses there was no correlation between depression at baseline and CRP at follow-up: least adjusted r = 0.047 (95% CI: − 0.007-0.100, p = 0.09); most adjusted r = 0.005 (95% CI: − 0.028-0.037, p = 0.772). Results from both the least (I 2 = 0.0%, Q statistic = 0.64; p = 0.43) and most (I 2 = 0.0%, Q statistic = 2.372; p = 0.50) adjusted analyses indicated low heterogeneity. The results from funnel plots and Eggers test for the most adjusted analysis (see Appendix C) indicated no publication bias.
Heterogeneity
For studies that examined both directions of association, there were differences in methodology, analysis, length of follow-up, confounders controlled for and population. However, these sources of heterogeneity did not seem to affect the depression to CRP relationship as no study found significance (see Table 3 ).
3.4.2.1. CRP to depression: Qualitative heterogeneity synthesis. All studies assessed depressive symptoms using rating scales, except for one study that also examined clinical depression (Forti et al., 2010) . However, this study did not find any association between CRP at baseline with the incidence of major depression over 4 years (Forti et al., 2010) .
There was heterogeneity in the measurement of depressive symptoms, scales utilised included the 8 and 20-item CES-D, 15 and 30-item GDS, Zung depression rating scale and Beck Depression Inventory (see Table 2 ). Six studies examined depressive symptoms categorically, with most using validated cut-offs (see Table 2 ), however the GDS-15 cut-off used by van den Biggelaar et al. (2007) was lower than other studies ≥ 2. Notably this study was the most significant study in both the least and most adjusted analysis, possibly because the cut-off used was lower (and thus would have included more depression cases) than other studies.
There was also heterogeneity in terms of confounders controlled for. Of the included studies, five adjusted for baseline depression (Au et al., 2015; Das, 2016; Stewart et al., 2009; van den Biggelaar et al., 2007; Zalli et al., 2016) , and three investigated incident depression (Forti et al., 2010; Hiles et al., 2015; Luukinen et al., 2010) . All studies that adjusted for baseline depression found a significant result for either their least or most adjusted analysis (see Table 2 ).
There was some heterogeneity also observed for measurement of CRP. Most studies examined CRP continuously (see Table 2 ), however three studies employed cut-offs for CRP. Of those studies, two used the same cut-off of ≥ 3 mg/dL (Au et al., 2015; Luukinen et al., 2010) and the other used quartiles with a similar cut-off of for the third quartile of ≥ 3.3 mg/dL (Forti et al., 2010) .
There was also heterogeneity between studies for the length of follow-up for studies which varied from 2.5 years (Luukinen et al., 2010) to 6 years (Stewart et al., 2009 ). However, there were no notable differences in results between studies based on length of follow-up (see Table 2 ). There was also heterogeneity evident in the population studied with ages of inclusion ranging from 50 to 85. However, there was no notable difference in study results based upon the age of participants (see Table 2 ).
There was some heterogeneity between studies for the health of the sample. Five studies also excluded people with evidence of systemic inflammation from their analysis (see Appendix B), and a further study examined this in a sensitivity analysis (Au et al., 2015) . However, there were no notable differences in significance between those studies that did versus did not exclude people for systemic inflammation.
There was some heterogeneity in terms of confounder control. One study did not control for confounders for CRP to depression (Hiles et al., 2015) , while all other studies provided adjusted estimates where they controlled for important confounders such as sociodemographics, lifestyle, medication, adiposity and chronic conditions (see Table 2 ). There were more studies that found significance in adjusted studies than nonadjusted studies (see Table 2 ).
3.4.2.2. CRP to depression: Quantitative heterogeneity synthesis. To ascertain if these sources of heterogeneity impacted on the study estimates we ran a series of sensitivity analyses (see Table 5 ). For the least-adjusted estimate, studies that investigated incidence of depression, used CRP as a categorical predictor, examined people aged 60 or older, or stratified by gender or systemic inflammation were all non-significant (see Table 5 ). For the most-adjusted analysis, there was no significant association for studies that investigated incidence of depression (rather than controlled for depressive symptoms at baseline), studies that had examined depressive symptoms continuously or examined CRP categorically (see Table 5 ). These results indicate that studies that control for baseline depressive symptoms rather than examine incident depression are more likely to find a significant association, as are studies that examine CRP continuously.
3.4.2.3. Depression to CRP: Qualitative heterogeneity synthesis. There was less observable heterogeneity for studies that examined the direction of association from depression to CRP with all four studies either being set in the UK or USA (see Table 3 ). For the depression to inflammation analyses, three studies adjusted for baseline inflammation (Au et al., 2015; Das, 2016; Stewart et al., 2009) , with the fourth study assessing change in inflammation as their outcome (Luciano et al., 2012) . The range in follow-up for studies ranged from 3 years (Luciano et al., 2012) to 6 years (Stewart et al., 2009) . Only one study examined their exposure and outcome categorically (Au et al., 2015) with all other studies modelling exposures and outcomes continuously. All studies controlled for important confounders, with two studies also providing least adjusted estimates (Au et al., 2015; Luciano et al., 2012) . Three of the four studies had a baseline study age of < 60 (Au et al., 2015 , Das, 2016 , Stewart et al., 2009 . All studies that examined depressive symptoms to CRP found no significant relationship for either the least or most adjusted estimate (see Table 3 ). As no statistical difference in results was uncovered and heterogeneity was low, we did not perform further sensitivity analyses.
Direction of causality
Of the three studies that examined the bi-directional relationship between depressive symptoms and CRP, two found a significant mostadjusted result from CRP to depression, but not vice versa (Das, 2016 , Stewart et al., 2009 . The third study also indicated that CRP led to depression rather than depression to CRP in their least adjusted analysis, however the effect was attenuated in their most adjusted analysis (Au et al., 2015) . These results taken in tandem with those discussed above indicate that CRP may lead to depression in older adults, rather than depression leading to CRP.
3.5. Study review and meta-analysis of the prospective association between IL-6 and depression 3.5.1. Prospective association between IL-6 and depression
In total five studies examined the prospective relationship between IL-6 at baseline to depression at follow-up, and one study examined the prospective relationship between depression at baseline with IL-6 at follow-up.
3.5.1.1. IL-6 to depression: Main results. Of the four studies that investigated the least adjusted association between IL-6 at baseline to depression at follow-up, two found significant associations (Hiles et al., 2015; Zalli et al., 2016) . For the five studies that provided a mostadjusted estimate, only one found a significant association (Zalli et al., 2016) .The random effects summary correlation coefficient indicated a small positive significant association between IL-6 at baseline and depressive symptoms at follow-up (Fig. 5a ) for the least adjusted estimate, r = 0.085 (95% CI: 0.039-0.131), p < 0.001. However, the significant effect was attenuated in the most adjusted estimate (Fig. 5b) , r = 0.034 (95% CI: − 0.007-0.074), p = 0.103.
There was low heterogeneity indicated from the least (I 2 = 6.01%, Q statistic = 4.26; p = 0.37) and most (I 2 = 14.66%, Q statistic = 5.86; p = 0.32) adjusted analyses. Publication bias was indicated by a significant Egger test (p = 0.05) for the least adjusted analysis (for funnel plots see Appendix C) but not the most adjusted analysis (Egger test, p = 0.16).
3.5.1.2. Depression to IL-6: Main results. Only one study investigated the direction of association from depression to IL-6 (Stewart et al., 2009 ). This study found that depressive symptoms as measured with the BDI-II were a predictor of 6-year change in IL-6, even after adjustment for demographic, biomedical, and behavioral factors. Since only one study investigated this association in a relatively healthy population, limited inferences can be made. Table 5 Sensitivity analyses for longitudinal associations. K.J. Smith et al. Experimental Gerontology 102 (2018) 109-132 3.5.2. 1IL-6 to depression: Qualitative heterogeneity synthesis As only one study examined depression to IL-6 the focus of this section is on the five studies that examined IL-6 to depression. As with previous studies, there was heterogeneity in terms of methodology, analysis, length of follow-up and confounders controlled for.
There was some heterogeneity evident for the measurement and modelling of depression. All included studies investigated depressive symptoms using validated scales, except Forti et al. (2010) who also included an estimate for high IL-6 leading to incident clinical depression. This study found no evidence that the highest two quartiles of IL-6 led to incident clinical depression or high depressive symptoms. Of those studies that investigated depressive symptoms, two used the CES-D, two used the GDS and one used the Beck Depression Inventory (see Table 3 ). Four of the five studies categorised depressive symptoms into high versus low, with the final study analyzing depressive symptoms continuously (Stewart et al., 2009 ). Therefore, the two studies that found a significant result had categorised depressive symptoms (Hiles et al., 2015 , Zalli et al., 2016 . There was also some heterogeneity for the measurement and modelling of IL-6. When examining how IL-6 was analyzed only one study examined cut-offs for IL-6 (Forti et al., 2010) with all other studies examining IL-6 continuously. Both studies that found a significant result analyzed IL-6 continuously (Hiles et al., 2015 , Zalli et al., 2016 .
There was minimal heterogeneity observed in terms of length of follow-up. The range in follow-up for studies ranged from 3.5 (Hiles et al., 2015) to 6 years (Stewart et al., 2009 ) and there were no systematic differences between results based on length of follow-up (see Table 2 ).
There was minimal heterogeneity in terms of confounders controlled for, as all studies provided a most-adjusted estimate that controlled for important sociodemographic, lifestyle, chronic conditions and adiposity factors (see Table 1 ). However, there was some heterogeneity in terms of how depressive symptoms were controlled for at baseline. Two of the studies examined incident depression (Forti et al., 2010; Hiles et al., 2015) , and the other three studies controlled for depressive symptoms at baseline (Stewart et al., 2009; van den Biggelaar et al., 2007; Zalli et al., 2016) . However, the observed differences did not appear to influence statistical results (see Table 2 ).
There was also heterogeneity in terms of the baseline health of the samples. Three studies controlled for systemic inflammation (Hiles et al., 2015; Stewart et al., 2009; van den Biggelaar et al., 2007) and one removed people with some chronic conditions from their analysis (Stewart et al., 2009 ). However, there were no systematic differences in statistical significance based on these study differences.
There were also some differences in the population studied. One study provided gender stratified analyses which indicated a significant least adjusted association in women but not men (Hiles et al., 2015) , however gender inferences are difficult to make as no other study stratified by this variable. Furthermore baseline study age ranged from 50 to 85 years old. However, no systematic differences in results were evident on the basis of age (see Table 2 ).
3.5.2.1. IL-6 to depression: Quantitative heterogeneity synthesis. We conducted a series of sensitivity analyses to determine whether these differences between studies could affect our meta-analysis (see Table 5 ). The least-adjusted estimate was reduced to non-significance in studies that controlled for depression at baseline and in studies where people with systemic inflammation were removed from the analysis. All estimates for the most-adjusted analysis remained non-significant. Due to the small number of studies in these sensitivity analyses, results should be interpreted with caution.
Discussion
We identified a total of 32 observational studies (23 cross-sectional, 7 longitudinal, and 2 assessing both cross-sectional and longitudinal associations) that examined the association between CRP and depression or IL-6 and depression among older adults from the community. Evidence from the least adjusted cross-sectional analyses indicated a weak but positive association between CRP and depression, which was attenuated after adjustment for confounding. There was also a weak positive significant association between IL-6 and depression, which remained significant after adjustment for confounding. There was no association between CRP and clinical depression, though there was a significant association between IL-6 and clinical depression even after adjustment for confounders.
Evidence from prospective analyses indicated that both CRP and IL-6 levels at baseline have a small but significant association with subsequent depressive symptoms, however this result only remained significant for CRP to depression after adjustment for confounding. There was no evidence for the direction of association from depression to CRP, and only one study investigated depression to IL-6 thus inferences were difficult to draw.
The results also demonstrated significant heterogeneity between studies in modelling of depression and inflammation, confounders controlled for, analytic strategies and populations studied. Many sources of heterogeneity affected our estimates in sensitivity analyses. For example, whether the health of the sample was accounted for. Furthermore, for prospective analyses the analysis of the exposure as 'incident' from baseline, or after adjustment for baseline levels of the exposure was an additional source of heterogeneity. We suggest sources of heterogeneity should be considered in future work that examine the association of inflammation and depression in older adults. For example, if depression and inflammation are analyzed categorically it could be worth undertaking a sensitivity analysis where they are analyzed continuously to determine the impact this has on results.
Previous work has proposed that inflammatory depression should be considered an important subtype of depression in older adults (Gallagher et al., 2017; Alexopoulos and Morimoto, 2011) . This subtype of depression has been associated with a higher risk of developing diabetes (Au et al., 2014) , a greater chronicity of depression (Gallagher et al., 2017) and is proposed to be involved in the pathogenesis of dementia (Leonard, 2007) . Thus, inflammatory depression in older adults is a serious issue. However, based on our work it is challenging to conclude the extent to which depression and inflammation are linked in older adults. The small effect size between both CRP and IL-6 with depressive symptoms and clinical depression suggests that the involvement of inflammation in depression as a condition is small.
The observed small effect size could be partly due to the fact we only included community-based samples. The cross-sectional metaanalysis conducted by Howren et al. (Howren et al., 2009 ) observed a much smaller association in community-based samples compared to clinical samples. Thus it is possible that the association of inflammation with depression is more pronounced in clinical samples, something we did not investigate in this study.
Our most-adjusted results indicated that IL-6 was linked with both clinical depression and depressive symptoms cross-sectionally but not longitudinally, whereas CRP was not linked with clinical depression or depressive symptoms cross-sectionally but were associated with an increased risk of depressive symptoms longitudinally. These heterogenous findings suggest that different inflammatory markers could have different associations with depression in older adults, with IL-6 being an indicator of current depressive symptoms and CRP being involved in the etiology of depression in older adults. However, these inferences are limited by findings from our sub-group analysis and the difficulty of inferring causality from observational studies. Furthermore, our work indicated there is more need for research to be done for the direction of association from depression to IL-6, as there is currently only one study that examines this association (Stewart et al., 2009) .
Our results also point to the importance of confounders such as chronic conditions, adiposity and lifestyle in explaining the cross-sectional association between depression and inflammation in older adults.
The estimate between CRP and depression was attenuated in the mostadjusted estimate, and the most-adjusted IL-6 and depression estimate was affected in sensitivity analyses that accounted for chronic conditions. Previous research proposes that the association between inflammation and depression is explained by cardiometabolic abnormalities (Au et al., 2015) and chronic conditions (Almeida et al., 2007) . Furthermore, meta-analyses suggest the relationship between IL-6 and depression may be attenuated by adjusted for lifestyle and adiposity (Dowlati et al., 2010; Hiles et al., 2012) . However, there are also other variables that could explain this relationship such as frailty (Soysal et al., 2016; Soysal et al., 2017) , physical activity Vancampfort et al., 2017) , physical disability (Cole and Dendukuri, 2003; Reuben et al., 2002) , bereavement (Cole and Dendukuri, 2003; Schultze-Florey et al., 2012) and social isolation (Cacioppo et al., 2010; Shankar et al., 2011 ) among many others. There is also evidence that rather than acting as confounders in the depression-inflammation relationship that some of these variables should instead be modelled as effect modifiers. Previous research has indicated that BMI and metabolic abnormalities are important variables that modify the association of depression with inflammation. For example, work from a Chinese study of adults aged 45 or older shows that the association between depression and CRP was only significant in those older people who were underweight (Qin et al., 2017) . Furthermore, research that stratified by depression and diabetes status showed that those people with both diabetes and depression had much higher levels of inflammation than those with depression or diabetes alone (Doyle et al., 2013) .
We suggest that consideration of the variables that may confound or modify the relationship between inflammation and depression in older adults should be carefully investigated in future work so we can better understand what may be driving these associations.
Another possible effect modifier to consider is the heterogeneity of depression itself, and the fact inflammation may be linked with particular subtypes of depression (Penninx et al., 2013a) or particular symptoms of depression (Gallagher et al., 2017) . There is some evidence that inflammation may be associated with the atypical subtype of depression (Lamers et al., 2013; Rudolf et al., 2014) which is characterized by overeating, weight gain and hypersomnia. Furthermore, there is evidence that inflammation may be linked primarily with somatic symptoms linked with depression (Duivis et al., 2013) such as hypersomnia (Irwin et al., 2016) , adiposity (Shelton and Miller, 2010) or psychomotor slowing (Brydon et al., 2008) . This could also explain why there was evidence for an association of depressive symptoms rather than clinical depression with CRP (because of high scores on somatic depression symptoms that are not necessarily indicative of a clinical depression).
The role of inflammation in depression has long been of interest to researchers, and previous work has theorised a bi-directional relationship between inflammation with depression (Kiecolt-Glaser et al., 2015) . Our work suggests that in older adults it may be inflammation that leads to depression, supporting results from a previous meta-analysis of longitudinal studies (Valkanova et al., 2013) . There are various biological explanations posited for this direction of association. Evidence shows pro-inflammatory cytokines can cross the blood-brain barrier and act directly on emotion-regulating brain structures involved in depression such as the amygdala (Penninx et al., 2013b; Krishnadas and Cavanagh, 2012) . Furthermore, administration of pro-inflammatory cytokines have also been shown to induce sickness behavior, a syndrome characterized by vegetative, somatic, and psychological symptoms that are similar to depression (Dantzer et al., 2008a) .
As older adults have higher levels of circulating cytokines and inflammation (Bruunsgaard et al., 2001; Chung et al., 2011; Chung et al., 2009; Krabbe et al., 2004) , it is plausible that increased inflammation may be a particularly important risk factor for the development of depression in this population.
As with all reviews there are limitations that should be borne in mind when interpreting results. The first is the notable between-study heterogeneity observed for both those studies that conducted cross sectional and prospective analyses.
There is evidence that additional inflammatory markers such as tumor necrosis factor-α, IL-1, IL-8 and IL-10 might also be involved in depression (Köhler et al., 2017) . Thus, it will be important for future work to examine different inflammatory markers.
An additional limitation is that our longitudinal analyses are based on a relatively small number of prospective studies (especially for the depression to inflammation direction) which may explain why some sensitivity analyses were reduced to non-significance. Further, most studies in the review assessed depressive symptoms rather than assessing clinical depression. Although the rating scales included have wellestablished psychometric properties and are commonly used in epidemiological studies they are not clinical diagnoses of depression. It is likely that inclusion criteria for the review (i.e., exclusion of clinical studies) precluded many studies that may have used diagnostic interviews for depression. However, our results indicate that it may be important to examine the association of clinical depression with inflammation and not just depressive symptomatology.
There was also some evidence of publication bias though this was minimal. Similarly, language bias may also be an issue. Although we did not restrict our search by language, only English publications could be reviewed, which may account for the reason that the majority of our studies were conducted in Western countries.
Despite our study limitations, our review includes several strengths. We conducted a comprehensive search from several databases. By including cross-sectional as well as prospective analyses, we were able to examine not only cross-sectional associations between CRP and IL-6 with depression, but we were also able to assess directionality via the longitudinal analyses. While the heterogeneity of studies included could be seen as a limitation we conducted a thorough analysis of these differences to uncover how they might affect results. Furthermore, by restricting our sample to older adults, we can more clearly make inferences about how inflammation and depression are linked in older adults.
Conclusion
Overall, findings from this review suggest that there is a complex cross-sectional and prospective relationship between CRP and IL-6 levels with depression which has been further complicated by heterogeneity between studies. We found evidence to indicate a weak but positive correlation between CRP and depression that was attenuated for the most-adjusted estimate. We also found evidence for a crosssectional association between IL-6 and depression that remained significant after adjustment. However, these results were impacted by sensitivity analyses for chronic conditions. Prospective analyses indicated a small positive correlation between both CRP and IL-6 levels at baseline with depressive symptoms at follow-up, which remained significant for CRP after adjusting for confounders. There was little evidence for the opposite direction of causality, though more research for this direction is needed especially for IL-6. Results suggest that inflammation as indicated by CRP and IL-6 are associated with depression in older adults, and it is likely that inflammation leads to depression rather than depression to inflammation. The heterogeneity between studies and results from sensitivity analyses also highlight the need for future studies to assess the role of potential confounders and moderators in the inflammation-depression relationship and carefully consider how variables will be analyzed for this relationship.
Supplementary data to this article can be found online at https:// doi.org/10.1016/j.exger.2017.12.005.
